Daily Market Movers 12-31-08

FEATURED COMPANY

NEXIA HOLDINGS INCORPORATED (OTCBB: NXHD)
"Up 100.00% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/NXHD.php

Company Profile:
http://www.otcpicks.com/nexia-holdings/nexia-holdings.htm

Nexia Holdings, Inc., headquartered in Salt Lake City, Utah, is a diversified holdings company with operations in real estate, health & beauty, and fashion retail. Nexia owns a majority interest in Landis Lifestyle Salon (www.landissalons.com), a hair salon built around the world-class Aveda™ product line. Through its Style Perfect, Inc. subsidiary, Nexia owns the innovative retail and design firm Black Chandelier and its related brands. Black Chandelier currently operates one retail location and online store at www.blackchandelier.com.

NXHD News:

December 22 - Nexia Outlines Marketing Efforts

Nexia Holdings, Inc. (OTCBB: NXHD) (OTC: GRNE) announced that management is both reviewing and planning for its advertising and marketing efforts in 2009. CEO Richard Surber stated that, "I first want our shareholders, employees, and customers to be aware of some of the unique and traditional marketing efforts that have occurred over 2008 and how we plan to improve upon those efforts in 2009."

The following is a list of traditional media which include magazines, newspapers, mailers, radio, email, press releases, and other means that we have used or been featured in during 2008:

* Salt Lake Tribune with a weekly readership of approximately 900,000 which we recently ran a half page ad this last weekend.

* Salt Lake Magazine is a high end magazine distributed throughout the Salt Lake Valley.

* IN Utah This Week is a weekly newspaper that features our companies on a weekly basis to the hipster crowd and has a circulation of about 40,000.

* Yellow Pages.

* Hometown Values is a discount mailer to thousands of households in the Salt Lake Valley.

* American Salon Magazine has ranked Landis Lifestyle Salon as the #1 salon in Utah.

* Utah Business Magazine has ranked Nexia as the 33rd largest public company in Utah based upon 2007 revenues.

* DEX Yellow Pages.

* Verizon Yellow Pages.

* M6 Marketing is a text messaging service; we recently signed a 12 month contract with them.

* KCPW Radio is the local station for National Public Radio. Nexia is a proud supporter of this station.

"Our biggest and most effective way to get the word out on our salon products and services is word of mouth at the local level coupled with throwing events to show our appreciation for our clients. I am cultivating my success into our New Artist Stylists," noted Logan Fast, Master Stylist at Landis Salons and newly appointed Vice President of Green Endeavors Ltd. (OTC: GRNE).

Fast continued, "In 2009, I will release more specifics on who we will be advertising with and how Nexia can generate further interest in its products and services. In addition to traditional marketing, I hope to be able to lay out how we intend to better inform the investment community about Nexia, this will focus heavily on our web presence.

"A critical element to Nexia's success will be to make sure that Nexia's marketing dollars continue to be well spent. I look forward to 2009 when our agreement with Clearvision International, Inc. kicks in with an estimated value of about $2M in media which should include celebrity endorsements, billboards, TV, radio, and more."

FEATURED COMPANY

GREENCHEK TECHNOLOGY INCORPORATED (OTCBB: GCHK)

Detailed Quote: http://www.otcpicks.com/quotes/GCHK.php

Company Profile:
www.otcpicks.com/greenchek-technology/greenchek-technology.htm

GreenChek Technology, Inc. manufactures and distributes hydrogen injection technology devices that primarily focus on mobile transportation applications and industrial generative power applications. It also provides mobile greenhouse gas emissions reduction technology. The company's Onboard Hydrogen Generation and Injection technology is used for emissions reduction technology and fuel economy enhancement in trucks, locomotives, and automobile engines. It has operations in the United States, Canada, Asia, and Europe. The company, formerly known as Ridgestone Resources, Inc., was founded in 2006 and is headquartered in San Francisco, California.

GCHK News:

November 13 - GreenChek Signs Strategic European Distribution Agreement

GreenChek Technology Inc. (OTCBB: GCHK), a leading globally focused provider of hydrogen based technology for mobile transportation and stationary power generation applications, reported today that they have signed a strategic European distribution agreement with Technical Environmental Solutions Europe Ltd. (TESEL). TESEL is a world-class and world-renowned distribution Company focused in Europe. The November 4, 2008, announcement of the Letter of Intent has been finalized by both parties.

GreenChek manufactures an emission reducing device simply known as the ERD 1.0, which can be retrofitted to any vehicle or combustible engine regardless of fuel source. This device reduces vehicle emissions as well as increases fuel economy.

GreenChek’s Chief Strategy Officer, Donald Walling, stated, “We are very pleased to have signed this agreement with TESEL. Our proven ERD addresses the specific needs of multiple verticals in the European transportation industry. The agreement with TESEL marks a major milestone on route to our plan for aggressive global distribution of the ERD unit.” Walling added, “Our partnership with TESEL gives us the knowledge and ability to address and navigate complex European Government and intricate European transportation industry needs.”

FEATURED COMPANY

COPPER KING MINING CORPORATION (OTC: CPRK)
"Up 4.35% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CPRK.php

Company Profile:
http://www.otcpicks.com/copper-king-mining/copper-king-mining.htm

Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.

CPRK News:

December 24 - Copper King Announces Compliance with Nevada Star Option and Agreement

Copper King Mining Corporation (OTC: CPRK) announced that its subsidiary, Western Utah Copper Company (WUCC), has fully complied with the Nevada Star Option and Agreement (the Option Agreement), by commencing production in full satisfaction with the requirements of the Option Agreement.

Mr. Monty Moore, former president and CEO of Nevada Star at the time of the Option Agreement’s execution, in an private interview said, " WUCC has overcome nearly insurmountable odds and obstacles, such as no commercial power, in order to comply with both the spirit and the letter of the Option Agreement as written and agreed to at the time."

As Nevada Star’s presiding officer at the time, Moore said, “WUCC has more than accomplished that which was agreed upon. The intent of the Option Agreement was that the properties be moved forward into production. In spite of periods of force majeure, properly excused by the Option Agreement, and even though substantial additional time still remains for WUCC to complete of the Option Agreement requirements as a result of the occurrence, recurrence and the extent of force majeure conditions, WUCC has steadily progressed in moving the project into production and fulfilling the requirements to complete the Option Agreement. Now, WUCC has constructed and is placing in operation a mill at a cost in excess of $50 million, and it certainly is apparent that completion of the Option Agreement requirements has been more than accomplished.”

FEATURED COMPANY

SPONGETECH DELIVERY SYSTEMS (OTCBB: SPNG)

Detailed Quote: http://www.otcpicks.com/quotes/SPNG.php

Company Profile: http://www.otcpicks.com/spongetech/spongetech.htm

SpongeTech Delivery Systems is a development stage company which designs, produces, markets and distributes cleaning products for vehicular use utilizing patented technology relating to sponges containing hydrophilic (liquid absorbing) foam polyurethane matrices. The Company's sponges are specially configured with an outer contact layer and an inner matrix, which is loaded with specially formulated soaps and wax that are released when the sponge is applied to a surface with minimal pressure. The Company's products are currently designed specifically for vehicular cleaning use. However, the Company is exploring the possibility of using its patented technology for the development of sponges for other uses, including for use with anti-bacterial, bath and kitchen soaps for household uses, as well as for use as a children's bath foam sponge.

SPNG News:

December 18 - SpongeTech® Delivery Systems, Inc. Announces Top 20 Ranking on Jordan Whitney 'Greensheet' Report

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG), “America's Cleaning Company™,” announced that, for the week ending December 10, 2008, its product reached No. 19 on the Jordan Whitney Top 60 Direct Response Spots for the same week. This report ranks the top sixty direct response spots which sell traditional Direct Response Television ("DRTV") products directly or indirectly (excluding music offers) based upon confidential media budgets and Jordan Whitney's monitoring of national cable and selected broadcast markets. Jordan Whitney, an independent clearinghouse, is one of the industry's oldest monitoring services that provide up-to-date information on DRTV, which include infomercials, short-form DRTV commercials, the websites for these products, and the companies involved in their production and distribution. Jordan Whitney also monitors media budgets for companies that utilize cable and broadcast direct response marketing television.

SpongeTech also reached the No. 12 spot on the Jordan Whitney Top 20 Short-Form Retail Products Report, which ranks the top 20 traditional short-form products using DRTV commercials that are two minutes or less in length.

SpongeTech's COO Steven Moskowitz stated, "These high rankings confirm that our efforts via TV, radio, and web are effectively finding our target consumers, and we will continue to be aggressive in our development of new commercials and spots to introduce our cutting-edge delivery system products throughout America and internationally in 2009."

SpongeTech® Delivery Systems, Inc. CEO Interviewed Live on Steve Crowley's American Scene Radio Show

SpongeTech's CEO Interview Aired Today on American Scene Radio Show

SpongeTech Delivery Systems, Inc. (OTCBB: SPNG), “America's Cleaning Company™,” announced that its CEO and President, Michael Metter, will be interviewed Dec. 18 on Steve Crowley's American Scene Radio Show at 9:24 a.m. EST. The interview can be heard live on BusinessTalkRadioNetwork® affiliate radio stations streamed on its website (www.businesstalkradio.net). You can find local radio stations by accessing the website, as well. Mr. Metter will be scheduled for future interviews on American Scene, where he will keep listeners updated on SpongeTech®'s products and developments.

FEATURED COMPANY

PERF GO GREEN HOLDINGS INCORPORATED (OTCBB: PGOG)
"Up 3.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/PGOG.php

Company Profile:
http://www.otcpicks.com/perf-go-green/perf-go-green.htm

Perf Go Green Holdings, Inc. is engaged in the creation and global marketing of 100% eco-friendly, non-toxic, food-contact-compliant, biodegradable plastic products. All Perf Go Green products are made from recycled plastics and completely break down in landfill within two years, leaving no toxic or visible residue, as compared to other plastics that take hundreds of years. Perf Go Green’s corporate name reflects its “Go Green” mission to develop, market and distribute biodegradable plastic products as a practical and viable solution to eliminating plastic waste from the world environment.

PGOG News:

December 15 - Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for Perf Go Green

Anthony Tracy, Chairman and CEO of Perf Go-Green Holdings, Inc. (OTCBB: PGOG) was a guest on Wall St. Network’s 3-Minute Press Show. To view this clip in its entirety, visit www.tv.wallst.net/r/3-minute-press/Anthony-Tracy/362/1447/. Ask Anthony a question, post a comment on his profile page, and join his financial social network today at http://my.wallst.net/Anthony-Tracy.

Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino that features in-depth interviews with public company executives on their company and most recent press releases.

The show is designed to provide viewers with insight into a company's latest news, and its impact on the company's growth.

FEATURED COMPANY

SOMATIC SYSTEMS INCORPORATED (OTC: SMAS)

Detailed Quote: http://www.otcpicks.com/quotes/SMAS.php

Company Profile:
http://www.otcpicks.com/somatic-systems/somatic-systems.htm

Somatic Systems is the worldwide center for Clinical Somatics™, the groundbreaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques — conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises lasting as little as 5 minutes a day — to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics™ also provides performance gains and injury prevention for casual and professional athletes. Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources and opportunities at www.somatics.org.

SMAS News:

December 17 - Somatic Systems, Inc. CEO Interviewed Live Thursday on Investment Nation

Somatic Systems, Inc. (OTC: SMAS) CEO Steven Aronstein will be featured tomorrow in an exclusive interview on Investment Nation (www.investmentnation.com). The live interview will be held and audio broadcast in the website's chatroom at 6:00 PM Eastern Time.

Shareholders should go to www.investmentnation.com and search for Somatic Systems to find the company's forum page and post their interview questions on the site in advance. Participants will also be able to ask questions at the time of the conference.

Earlier this month, it was announced that the Investment Nation website would begin featuring monthly interviews with Somatic Systems' CEO based on shareholder questions, to keep shareholders updated with the company's latest plans and to get timely answers to their pressing questions. Somatic Systems has stated it is always seeking more ways to communicate with shareholders and maintain transparency, and the company sees the Investor Nation monthly interviews as an exciting opportunity to expand this conversation.

Investment Nation provides an online forum for shareholders and other investors to share facts, due diligence and investment ideas about the Somatic Systems. Investment Nation was built to provide a forum for new and experienced investors to gather and share market information in a clean and professional environment. The site is designed to be user-friendly and simple, allowing investors to get the market information they need quickly and easily. Everything about the site was put together based on investors needs. Investment Nation limits both the stock pumping and bashing found on other investment forums along with cracking down on paid bashers and stock promoters.

Somatic Systems has been involved with numerous high profile activities recently, including becoming registered as a US government contractor, meetings with the US military to become a fully approved health care service, and dramatically increased media coverage including current national and international television appearances on MoneyTV — a financial industry talk show airing last week to greater than 100 million households — and Health Forum — a syndicated health feature airing 50 times including on the WE tv network this morning to over 70 million households. The Investment Nation feature interviews are a timely opportunity to follow Somatic Systems during this exciting time for the company.

STOCKS TO WATCH

CONSTAR INTERNATIONAL INCORPORATED (NASDAQ: CNST)
"Up 78.55% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CNST.php

Philadelphia-based Constar is a leading global producer of PET (polyethylene terephthalate) plastic containers for food, soft drinks and water. The Company provides full-service packaging solutions, from product design and engineering, to ongoing customer support. Its customers include many of the world's leading branded consumer products companies.

CNST News:

December 30 - Constar International Inc. Receives Support from the Holders of a Majority in Principal Amount of the Subordinated Notes for Plan to Reduce Debt and Annual Interest Expense

Company Files Pre-Arranged Voluntary Chapter 11 Petition To Implement Debt-For-Equity Swap; No Other Creditor Classes Impaired Ongoing Business Relationships With Suppliers, Customers and Employees Not Impacted By Restructuring

Constar International Inc. (Nasdaq: CNST) announced that it has received support from the holders of a majority in principal amount of the Company’s Subordinated Notes regarding a debt-for-equity exchange that will reduce the Company’s outstanding indebtedness by $175 million and reduce its annual interest expense by approximately $19.3 million. To implement this pre-arranged restructuring, Constar and certain of its subsidiaries today filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court in Wilmington, Delaware.

All of Constar’s global operations – including all of its manufacturing and distribution facilities in the U.S. and Europe – are open and operating on normal schedules, and the Company expects to continue to fulfill all customer orders as usual and provide uninterrupted customer service.

Michael Hoffman, President and CEO of Constar, said, “We are pleased to have received support from the holders of a majority in principal amount of our subordinated notes for a pre-arranged and consensual restructuring that significantly improves our balance sheet by eliminating $175 million in debt, reduces our annual cash interest obligations by approximately $19.3 million, and frees up cash to reinvest in our business to support future growth. We intend to continue to operate as usual during the restructuring process with minimal disruption to the business and our constituencies. We intend to pay all of our obligations in full – which includes providing pay and benefits to our employees as usual, honoring all contracts, and paying suppliers in full.”

Pursuant to the Company’s proposed plan of reorganization, holders of the Subordinated Notes will convert 100% of the face amount of the Subordinated Notes and the full amount of the interest payment due December 1, 2008, which will not be paid, into common stock of the reorganized company. The Company’s current equity will be cancelled, but all other creditor classes will be unimpaired. Importantly, all obligations owed by the Company to trade creditors in the ordinary course of business will be paid in full under the plan. The Company anticipates that the restructuring will be completed by early spring of 2009.

Allan Brilliant, partner at Goodwin Procter LLP, counsel to an ad hoc committee of holders of the Subordinated Notes, said, "Our clients support the Company's efforts to deleverage through a debt-for-equity exchange under a plan that proactively fixes the balance sheet and allows the company to realize its full potential."

Christopher Pucillo, Chief Investment Officer of Solus Alternative Asset Management LP, the largest holder of Constar’s Subordinated Notes, said, "As the largest holder of Subordinated Notes, we support the deleveraging under the plan. We look forward to working with Constar to consummate the debt-for-equity exchange promptly to allow the Company to maximize its potential prospects going forward."

Constar also announced today that it has received commitments from its existing bank lenders to provide the Company with debtor-in-possession (“DIP”) and exit financing of $75 million. The DIP financing will help enable the Company to continue to satisfy customary obligations associated with ongoing operations of its business, including the timely payment of employee obligations, materials purchases, normal operating expenses and other obligations. The $75 million exit financing facility provides for committed financing for the three years following the closing of the DIP financing. In addition, Constar has filed a variety of customary first day motions with the Court that will allow it to continue to conduct business as usual while it completes the debt-for-equity restructuring.

The Company’s financial advisor is Greenhill & Co. and its legal advisors are Wilmer Cutler Pickering Hale and Dorr LLP and Bayard, P.A.

VITESSE SEMICONDUCTOR (OTC: VTSS)
"Up 113.33% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/VTSS.php

Vitesse designs, develops and markets a diverse portfolio of high-performance, cost-competitive semiconductor solutions for Carrier and Enterprise networks worldwide. Engineering excellence and dedicated customer service distinguish Vitesse as an industry leader in Gigabit Ethernet LAN, Ethernet-over-SONET, Fibre Channel, Optical Transport, and other applications. Vitesse innovation empowers customers to deliver superior products for Enterprise, Access, Metro, and Core applications.

VTSS News:

December 30 - Vitesse Reports Fiscal 2008 Year End Results

Achieves Profitability and Compliance with SEC Filings

Vitesse Semiconductor Corporation (OTC: VTSS), a leading provider of advanced IC solutions for Carrier and Enterprise networks, achieved profitability for the fiscal year ended September 30, 2008 with net income of $16.6 million, or $0.07 net income per share, and today filed an annual report on Form 10-K with the Securities and Exchange Commission to report the Company’s fiscal year 2008 results of operations and financial condition. Vitesse also filed quarterly reports on Forms 10-Q for the periods ended December 31, 2007, March 31, 2008, and June 30, 2008 and is once again current with respect to its Exchange Act reporting obligations.

“Vitesse has emerged from some very formidable times as a stronger and profitable business. We have taken concrete steps to improve our strategic direction, product execution, operational efficiency, and customer loyalty,” said Chris Gardner, chief executive officer of Vitesse. “The results are a dramatic three-year trend of improved operational and financial performance. During this time, we have strengthened substantially every financial metric including: revenue, margins, operating income, net income, net debt, and cash. While we still have some challenges ahead, we now have a sound base on which to build, and we remain as committed as ever to improving shareholder value.”

Recap of Fiscal Year 2008 Results

As discussed in greater detail in the Company’s fiscal year 2008 Form 10-K, Vitesse announces fiscal year 2008 highlights as follows:

* Net revenues in fiscal year 2008 were $228.5 million, an increase of 3% compared with the $221.9 million reported for fiscal year 2007;

* Revenue for the licensing of intellectual property was $10.0 million in fiscal year 2008;

* Cost of revenues for fiscal year 2008 was $106.3 million, or 47% of revenues, a decrease from $113.8 million, or 51% of revenues for fiscal year ended 2007;

* Income from operations in fiscal year 2008 was $8.4 million compared to a loss from operations of $1.8 million for fiscal year 2007. Income from operations in fiscal year 2008 includes charges of $10.8 million related to professional fees associated with the completion of its internal accounting investigation, actions to improve internal controls and preparation of its financial statements. The fiscal year 2007 loss from operations included the same professional charges totaling $13.6 million;

* Net income for fiscal year 2008 was $16.6 million, or $0.07 net income per share, compared to net loss of $21.6 million, or $0.10 loss per share, for fiscal year 2007; and

* Cash position as of September 30, 2008 was $36.7 million.

Investors should review these financial results in conjunction with the more comprehensive information regarding the Company’s results of operations and financial condition included in its fiscal year 2008 Form 10-K.

Conference Call Information

A conference call is scheduled for Tuesday, January 6, 2009, at 8:00 a.m. Eastern Time. To listen to the conference call via telephone, dial 800-450-5178 (U.S. toll-free) or 706-679-6171 (International) and provide the passcode 79385488. Participants should dial in at least 10 minutes prior to the start of the call. The Company will also broadcast the conference call via a webcast over the internet. To listen to the webcast, please visit the investors section of the Vitesse website at www.vitesse.com. The call will be recorded and available for replay until Tuesday, January 13, 2009. To access the audio replay, dial 800-642-1687 (U.S. toll-free) or 706-645-9291 (International) and provide the passcode 79385488.

Investor Conference Participation

Vitesse will participate in the 11th Annual Needham & Company Growth Stock Conference, January 6 – 8, 2009. Representing Vitesse at this event will be Chris Gardner, CEO, and Rich Yonker, CFO. They will present on Wednesday, January 7, 2009 at 3:30 pm Eastern Time. The presentation will be webcast.

LABOPHARM INCORPORATED (NASDAQ: DDSS)
"Up 44.45% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/DDSS.php

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally and its second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products.

DDSS News:

December 31 - Labopharm Announces FDA Approval of Once-Daily RYZOLT™ (Tramadol HCL Extended Release Tablets) for Management of Moderate to Moderately Severe Chronic Pain

Labopharm Inc. (Nasdaq: DDSS) (TSX: DDS) announced that RYZOLT™ (tramadol HCl extended release tablets), Labopharm's once-daily formulation of the analgesic tramadol, has been approved by the U.S. Food and Drug Administration (FDA). RYZOLT is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

"The approval of our first product in the United States is a major milestone for our Company and we look forward to our product's launch in the world's largest market for pain medications," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "We believe that RYZOLT offers physicians and patients an excellent option for the treatment of pain with the benefit of once-daily dosing. We look forward to the launch of our product by our marketing partner for the U.S., Purdue Pharma."

RYZOLT is a centrally acting analgesic composed of a dual-matrix delivery system with both immediate-release and extended-release characteristics. Labopharm's marketing partner for its product in the United States, Purdue Pharma L.P., anticipates launching RYZOLT tablets in 100 mg, 200 mg and 300 mg dosage strengths in the second quarter of 2009.

The approval of RYZOLT is the first U.S. FDA approval that Labopharm has obtained for a medication using its patented Contramid® controlled-release technology for oral administration of solid dosage medications. Labopharm believes that its Contramid technology can be applied to a wide range of complex, small, highly water soluble molecules to control their release over a 24-hour period with a desired pharmacokinetic profile.

Pain is a potentially debilitating condition that affects an estimated 75 million Americans - more than diabetes, heart disease and cancer combined. The United States is the world's largest market for tramadol products with sales for the 12-month period ended September 2008 of more than US$650 million resulting from more than 25 million prescriptions, which have grown at a compounded annual rate of 11% over the last five corresponding periods. Labopharm believes, however, that RYZOLT will compete not only with other tramadol products, but also with other medications indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.

"In a society where people with pain are increasingly demanding simplified dosing regimens, this once-daily formulation of tramadol should be embraced by physicians and patients alike," said Nicholas J. Messina III, MD, with Vista Medical Research Inc., Mesa, AZ, who was a principal investigator in the U.S. clinical studies on RYZOLT.

Labopharm will host a conference call on Tuesday, January 6, 2009 to discuss this announcement. Additional details for the conference call will be provided via separate news release shortly.

ABOUT THE GLOBAL COMMERCIALIZATION PROGRAM FOR LABOPHARM'S ONCE-DAILY TRAMADOL PRODUCT

Labopharm's once-daily tramadol product is being commercialized globally and to date has been launched in 14 countries, including Canada and the five largest individual markets in Europe. In addition, it has received regulatory approval or is under regulatory review in 29 countries and the Company has established marketing partnerships for its product in 38 countries. Labopharm is continuing to pursue regulatory approval and marketing partnerships for its once-daily tramadol product for other markets around the world in support of its global commercialization program.

CHINA BAK BATTERY INCORPORATED (NASDAQ: CBAK)
"Up 35.54% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/CBAK.php

China BAK Battery, Inc. is one of the largest manufacturers of lithium-based battery cells in the world, as measured by production output. It produces battery cells that are the principal component of rechargeable batteries commonly used in cellular phones, notebook computers and portable consumer electronics, such as digital media devices, portable media players, portable audio players, portable gaming devices and personal digital assistants (or PDAs), and other applications, such as cordless power tools and minings lamp. China BAK's 3.0 million square feet of facilities are located in Shenzhen and Tianjin, PRC, and have been recently expanded to produce new products.

CBAK News:

December 31 - China BAK Announces Conference Call to Discuss First Quarter FY 2009 Results

China BAK Battery Inc. (Nasdaq: CBAK), one of the largest lithium-ion battery cell manufacturers in the world, as measured by production output, will host a conference call at 7:00 pm Eastern Time on Friday, January 23, 2009, to discuss results for the first quarter of fiscal year 2009.

China BAK's senior management team, led by Xiangqian Li, China BAK's President and Chief Executive Officer, will present at the conference call and answer questions.

To participate in the conference call, please dial the following number approximately fifteen minutes prior to the scheduled conference call time: 888-482-0024. International callers should dial (617) 801-9702. The pass code for the call is 525-335-07.

If you are unable to participate in the call at this time, a replay will be available on Friday, January 23 at 9:00 pm ET, through Saturday, February 7, at 9:00 pm ET. To access the replay, please dial 888-286-8010. International callers should dial (617) 801-6888 and enter the pass code 639-38-928.

This conference call will be broadcast live over the Internet and can be accessed by all interested parties on the CBAK website at www.bak.com.cn. To listen to the live webcast, please go to the CBAK website at least fifteen minutes prior to the start of the call to register, download, and install any necessary audio software. For those unable to participate during the live broadcast, a replay will be available shortly after the call on CBAK's website for one year.

AKORN INCORPORATED (NASDAQ: AKRX)
"Up 23.08% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/AKRX.php

Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals.

AKRX News:

December 31 - Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package

Akorn-Strides, LLC announced that the U.S. Food and Drug Administration has granted approvals for two Abbreviated New Drug Applications (ANDAs) for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package. Akorn-Strides, LLC is a Joint Venture that was formed in 2004 by Akorn, Inc. (Nasdaq: AKRX) and Strides Arcolab Limited (NSE: STAR) (BSE: 532531). The primary mission for the Joint Venture is to develop liquid, lyophilized and dry powder formulations of generic injectable products targeting several therapeutic markets with a major focus on anti-infectives, analgesics and CNS medicines.

Sterile Vancomycin HCl is an antibiotic indicated for the treatment of potentially life-threatening infections which cannot be treated with other effective antimicrobial drugs, including the penicillins and cephalosporins. Recent IMS data estimates an annual market size for Sterile Vancomycin HCl of approximately $150 million. The expected launch date for these two new products is the first half of 2009.

The current product portfolio of the Joint Venture, which is funded equally by Akorn and Strides Arcolab, was recently expanded and now includes 29 ANDA’s with a total of 53 SKU's, or product line offerings. To date, the Joint Venture has filed for 18 ANDA’s and received 14 ANDA approvals. The Joint Venture generated its initial product revenues in the third quarter of 2008, from the launch of Rifampin for Injection.

Arthur S. Przybyl, Akorn’s President and CEO and Member Manager of Akorn-Strides, LLC stated, “These two important product approvals represent the largest market size opportunity for the Joint Venture to date. I would like to personally thank Arun Kumar, co-founder of the Akorn-Strides Joint Venture, for having built the necessary manufacturing infrastructure to allow the Joint Venture to effectively compete for market share.”

ABOUT STRIDES ARCOLAB LIMITED

Strides, listed on the Bombay Stock Exchange Limited (532531) and National Stock Exchange of India Limited (STAR), is one of India’s largest exporters of branded generic pharmaceutical products. Strides manufactures pharmaceutical formulations in various dosage forms, including capsules, tablets and liquid injectables and is one of the world’s top five manufacturers of softgel capsules. Strides also has the only globally dedicated softgel facility for hormones. In addition, Strides undertakes contract research and the manufacturing of specialty chemicals for various multinational companies. Strides has a major presence in various developing countries such as Africa, Latin America and Asia as well as in developed markets such as the U.S., Canada and part of Europe. Strides is one of the largest Indian suppliers of institutionally funded aid projects and is an approved supplier to the Global Drug Facility, UNICEF, and MSF amongst others.

Strides has 14 manufacturing plants spread across the U.S., Brazil, Mexico, Italy, Poland, Singapore and India. This broad manufacturing network facilitates partnering with global organizations ranging from UNICEF and WHO-Global Drug Facility to European and American pharmaceutical multinationals, private labelers and distribution chains. Strides has product registrations in over 37 countries around the world and has earned ISO 9001, ISO 14001 and GMP accreditations including USFDA. Strides employs approximately 1,700 people across the globe. Strides also has a marketing presence in over 50 countries.

XO HOLDINGS INCORPORATED (OTCBB: XOHO)
"Up 7.14% in morning trading"

Detailed Quote: http://www.otcpicks.com/quotes/XOHO.php

XO Communications, a subsidiary of XO Holdings, Inc., is a leading nationwide provider of advanced communications services and solutions for businesses, enterprises, government, carriers and service providers. Its customers include more than half of the Fortune 500, in addition to leading cable companies, carriers, content providers and mobile network operators. Utilizing its unique combination of high-capacity nationwide and metro networks and broadband wireless capabilities, XO offers customers a broad range of managed voice, data and IP services with proven performance, scalability and value in more than 75 metropolitan markets across the United States.

XOHO News:

December 9 - XO Communications and Digium® Announce Interoperability Certification

Certification Ensures Interoperability of Digium's Award-Winning Switchvox® IP PBX With XO's Award-Winning SIP Converged VoIP and Data Solution

XO Communications (OTCBB: XOHO) and Digium®, the Asterisk® Company, announced that Digium's Switchvox® IP PBX has been certified to work with XO's award-winning Session Initiation Protocol trunking solution, XO SIP. The certification will streamline the adoption of XO SIP by users of the award-winning Switchvox telephony system and offer them a cost-effective and efficient way to connect to the public phone network without having to rely on traditional land lines.

This announcement begins a collaboration between two leading providers of VoIP services and solutions for businesses. Today, more than 15,000 businesses and more than 500,000 customer employees benefit from VoIP services offered by XO through its portfolio of converged services, which includes XO SIP and XO IP Flex. Digium's Asterisk is the world's most widely used open source telephony software, and Switchvox is the most widely used customer premise-based IP PBX based on Asterisk.

"Businesses are looking for both high-performance and cost-effective VoIP solutions that are easy to deploy and manage," said Nicola Jackson, director of voice and converged services for XO Communications. "Together, Digium's feature-rich Switchvox platform and XO SIP offer an affordable, high-quality VoIP solution that businesses can deploy rapidly. Completing interoperability with Digium Switchvox platform enables us to offer businesses more options when selecting their SIP trunking services provider."

The certification confirms that Switchvox and XO SIP work seamlessly together, providing businesses with confidence when using their feature-rich, easy-to-use, inexpensive Switchvox phone system with XO SIP.

"Companies that want to integrate voice and data with Switchvox are now assured of full interoperability when they select XO for their IP network," said Leslie Conway, vice president of global marketing for Digium. "SMBs and solution providers want certified solutions that have been thoroughly tested. Formal XO certification now provides them with a high level of confidence in choosing Digium and XO as a combined solution for their network needs."

ABOUT XO SIP

XO SIP is a fully integrated solution designed to support the needs of businesses with the most demanding voice and data applications at single or multiple locations. XO SIP uses Session Initiation Protocol signaling and a native IP-based facility to manage all traffic between a customer's IP PBX system, the XO IP network, and the Public Switched Telephone Network. The service provides greater efficiencies by eliminating the need for businesses to maintain multiple access facilities for voice and data services and eliminates the need for bandwidth-consuming protocol conversions.

XO SIP includes a broad range of bandwidth options to maintain optimal network performance and has the following features:

* Dedicated Internet access with dynamic bandwidth allocation
* Unlimited local calling
* Unlimited site-to-site calling for multi-location customers with IP Flex, IP Flex with VPN and XO SIP locations
* Long distance calling with choice of calling plans
* Optional Voice Compression
* Online Feature Management through the XO Business Center

ABOUT SWITCHVOX

Switchvox provides a full-featured telephony system that integrates with key CRM applications such as Salesforce.com and SugarCRM through Switchvox's SMB Switchboard interface. Switchvox delivers the benefits of integrating voice with data by enabling customers to create custom mashups that leverage other Web applications in seconds, with no programming knowledge required. The product equips small, midsize and growing businesses with a telephony solution that costs a fraction of the price of traditional phone systems.